About Conference

Why to Attend

Who Can Attend?

1. Rheumatologists
2. Orthopedic surgeons
3. Endocrinologists
4. Geriatricians
5. Physiatrists
6. Primary care physicians
7. Rehabilitation specialists
8. Physical therapists
9. Occupational therapists
10. Radiologists
11. Nurses specializing in musculoskeletal health
12. Researchers in the fields of osteoporosis, arthritis, and musculoskeletal disorders
13. Pharmacists with an interest in bone health and rheumatology
14. Dietitians and nutritionists focusing on bone health and inflammation
15. Public health professionals involved in musculoskeletal health promotion and prevention
16. Health policymakers and administrators concerned with musculoskeletal health initiatives
17. Medical students and residents interested in rheumatology and orthopedics
18. Industry professionals involved in the development of diagnostic tools, medications, and medical devices for musculoskeletal disorders
19. Patient advocates and representatives from patient advocacy organizations focused on osteoporosis, arthritis, and related conditions
20. Allied health professionals, such as chiropractors and podiatrists, with a focus on musculoskeletal health.

Session & Track

1. Genetics and Epigenetics of Osteoporosis

2. Inflammation and Autoimmunity in Arthritis

3. Bone Remodeling and Metabolism

4. Imaging Techniques in Musculoskeletal Disorders

5. Biomarkers for Disease Diagnosis and Prognosis

6. Pharmacological Interventions for Osteoporosis

7. Biological Therapies for Rheumatoid Arthritis

8. Nutritional Strategies for Bone Health

9. Exercise and Physical Therapy in Musculoskeletal Health

10. Surgical Management of Osteoporotic Fractures

11. Comorbidity Management in Musculoskeletal Disorders

12. Pediatric Rheumatology

13. Bone Health in Aging Populations

14. Regenerative Medicine and Tissue Engineering

15. Digital Health Technologies in Musculoskeletal Care

16. Psychosocial Aspects of Chronic Pain

17. Health Economics and Healthcare Policy

18. Environmental and Occupational Risk Factors

19. Patient-Centered Care and Shared Decision Making

20. Translational Research and Therapeutic Innovations

Participant Options & Benefits

We are pleased to offer a range of participation options for the upcoming 4th International Conference on Osteoporosis, Arthritis, and Musculoskeletal Disorders, providing attendees with diverse opportunities to engage, learn, and contribute to the advancement of musculoskeletal health research and practice.

1. Presenter: Share your latest research findings, innovative approaches, and clinical experiences with an international audience of peers and experts. Choose from oral presentations, poster presentations, or e-poster presentations to showcase your work and receive valuable feedback from fellow participants.

2. Attendee: Immerse yourself in two days of enriching sessions, keynote lectures, and interactive workshops led by renowned experts in the field of osteoporosis, arthritis, and musculoskeletal disorders. Gain insights into cutting-edge research, emerging trends, and best practices in musculoskeletal health management.

3. Workshop Participant: Participate in specialized workshops and hands-on training sessions covering topics such as advanced imaging techniques, biomechanical analysis, and clinical skills development. Enhance your practical skills and knowledge under the guidance of experienced instructors.

4. Exhibitor: Showcase your products, services, and technologies to a targeted audience of healthcare professionals, researchers, and industry leaders. Connect with potential collaborators, customers, and partners while increasing visibility for your organization within the musculoskeletal health community.

5. Sponsor: Demonstrate your commitment to advancing musculoskeletal health research, education, and patient care by sponsoring the conference. Enjoy prominent recognition, brand exposure, and networking opportunities while supporting a worthwhile cause.

Benefits of Participation:

• Knowledge Exchange: Gain access to the latest research findings, clinical insights, and technological advancements in osteoporosis, arthritis, and musculoskeletal disorders.

• Networking Opportunities: Connect with a diverse community of professionals, researchers, clinicians, and industry representatives from around the world, fostering collaborations and partnerships that drive innovation and impact.

• Continuing Education: Earn Continuing Medical Education (CME) and Continuing Professional Development (CPD) credits by attending accredited sessions and workshops, enhancing your professional development and credentials.

• Exposure and Visibility: Showcase your expertise, research, products, or services to a global audience, increasing recognition and awareness within the musculoskeletal health community.

• Contribution to the Field: Contribute to the advancement of musculoskeletal health research, practice, and policy by sharing your insights, experiences, and contributions with fellow participants.

We invite you to join us in Rome, Italy, on September 12-13, 2024, for an enriching and rewarding conference experience. Whether you are a researcher, clinician, industry professional, or student, there is a participation option that aligns with your interests and goals.

Market Analysis

The market size of musculoskeletal diseases is projected to reach $7.9 billion by 2027, with a forecasted Compound Annual Growth Rate (CAGR) of 6.9% between 2022 and 2027. Musculoskeletal disorders (MSDs) encompass injuries or ailments affecting muscles, nerves, tendons, joints, cartilage, and spinal discs. Defined by the Department of Labor's Bureau of Labor Statistics, MSDs include conditions resulting from repetitive motion, overexertion, or bodily reactions such as bending, climbing, crawling, reaching, or twisting. MSDs do not cover disorders caused by falls, trips, slips, or similar events. The most prevalent musculoskeletal diseases reported by bone and joint disease organizations are arthritis, back pain, and trauma. Annually, patients seek treatment for these conditions in hospitals, emergency care, and physician practices. Treating major musculoskeletal diseases incurs higher costs compared to many other medical conditions due to their tendency to cause long-term pain and disability.

According to a recent analysis of Global Burden of Disease (GBD) 2019 data, approximately 1.71 billion individuals worldwide suffer from musculoskeletal disorders, including rheumatoid arthritis, osteoarthritis, low back pain, neck discomfort, fractures, and other injuries. The global prevalence of musculoskeletal diseases, coupled with their increasing incidence, particularly among aging populations, drives new research and development initiatives in this field. Leading groups such as Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic, Wright Medical Group, and others contribute significantly to the growth of the musculoskeletal disease industry during the forecast period from 2022 to 2027.

Related Societies and Associations

1. International Osteoporosis Foundation (IOF)

2. American College of Rheumatology (ACR)

3. European League Against Rheumatism (EULAR)

4. National Osteoporosis Foundation (NOF)

5. American Society for Bone and Mineral Research (ASBMR)

6. Osteoporosis Canada

7. Australian Rheumatology Association (ARA)

8. British Society for Rheumatology (BSR)

9. Canadian Rheumatology Association (CRA)

10. International Society for Clinical Densitometry (ISCD)

11. The Arthritis Society (Canada)

12. National Rheumatoid Arthritis Society (NRAS)

13. The Osteoarthritis Research Society International (OARSI)

14. International Society of Musculoskeletal and Neuronal Interactions (ISMNI)

15. Australasian Society of Clinical Immunology and Allergy (ASCIA)

16. International Society for Clinical Rehabilitation of Osteoporosis (ISCRO)

17. European Federation of National Associations of Orthopaedics and Traumatology (EFORT)

18. American Orthopaedic Association (AOA)

19. Asia Pacific League of Associations for Rheumatology (APLAR)

20. International Skeletal Society (ISS)